Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 16 Jul 2026 for Annexin Pharmaceuticals AB (publ), €5,394. Read the official filing
Filing timeline
BuySaleCurt Mikael von Euler-Chelpin
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Curt Mikael von Euler-Chelpin: trading record in brief
Curt Mikael von Euler-Chelpin discloses dealings in Annexin Pharmaceuticals AB (publ) to Finansinspektionen. The record holds 3 filings, for trades running from 4 June 2024 to 9 July 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 16 July 2026: a transaction of €5,394, in Annexin Pharmaceuticals AB (publ). Typically, a trade is published a median of 4 days after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Companies and markets linked to Curt Mikael von Euler-Chelpin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
5,000 shares@ SEK 12.00BTA (betald tecknad aktie)ISIN SE0009664154FI:csv-574670a461c3e110e5ed
Canonical exit: 7 Oct 2026 (T+90)
1 of 1 declaration
